Harald Hampel, MD, PhD, MA, MSc
Harald Hampel, MD, PhD, MA, MSc
Chief Medical Officer, Senior Vice President, Eisai Inc.
Verified email at - Homepage
Cited by
Cited by
Inflammation and Alzheimer’s disease
H Akiyama, S Barger, S Barnum, B Bradt, J Bauer, GM Cole, NR Cooper, ...
Neurobiology of Aging 21 (3), 383-421, 2000
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ...
Nature Genetics 45 (12), 1452-1458, 2013
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ...
The Lancet Neurology 13 (6), 614-629, 2014
Mild cognitive impairment
S Gauthier, B Reisberg, M Zaudig, RC Petersen, K Ritchie, K Broich, ...
The Lancet 367 (9518), 1262-1270, 2006
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
D Harold, R Abraham, P Hollingworth, R Sims, A Gerrish, ML Hamshere, ...
Nature Genetics 41 (10), 1088-1093, 2009
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
T Jonsson, H Stefansson, S Steinberg, I Jonsdottir, PV Jonsson, ...
New England Journal of Medicine 368 (2), 107-116, 2013
Revising the definition of Alzheimer's disease: a new lexicon
B Dubois, HH Feldman, C Jacova, JL Cummings, ST DeKosky, ...
The Lancet Neurology 9 (11), 1118-1127, 2010
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature Genetics 51 (3), 414-430, 2019
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ...
Nature Genetics 43 (5), 429-435, 2011
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
K Blennow, H Hampel, M Weiner, H Zetterberg
Nature Reviews Neurology 6 (3), 131-144, 2010
Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria
B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ...
Alzheimer's & Dementia 12 (3), 292-323, 2016
CSF markers for incipient Alzheimer's disease
K Blennow, H Hampel
The Lancet Neurology 2 (10), 605-613, 2003
A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers
CR Jack Jr, DA Bennett, K Blennow, MC Carrillo, HH Feldman, GB Frisoni, ...
Neurology 87 (5), 539-547, 2016
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
JAMA 313 (19), 1924-1938, 2015
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ...
JAMA 302 (4), 385-393, 2009
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
H Hampel, MM Mesulam, AC Cuello, MR Farlow, E Giacobini, ...
Brain 141 (7), 1917-1933, 2018
Analysis of shared heritability in common disorders of the brain
Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ...
Science 360 (6395), eaap8757, 2018
New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ...
Nature genetics 54 (4), 412-436, 2022
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature Genetics 49 (9), 1373-1384, 2017
Classifying brain states and determining the discriminating activation patterns: support vector machine on functional MRI data
J Mourao-Miranda, ALW Bokde, C Born, H Hampel, M Stetter
Neuroimage 28 (4), 980-995, 2005
The system can't perform the operation now. Try again later.
Articles 1–20